APA (7th ed.) Citation

Hammer, F., Genser, B., Dieplinger, B., Egger, M., Müller, T., Drechsler, C., . . . Krane, V. (2022). Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus. Clinical kidney journal, 15(10), . https://doi.org/10.1093/ckj/sfac142

Chicago Style (17th ed.) Citation

Hammer, Fabian, et al. "Soluble Suppression of Tumorigenesis-2 Is a Strong Predictor of All-cause, Cardiovascular and Infection-related Mortality Risk in Haemodialysis Patients with Diabetes Mellitus." Clinical Kidney Journal 15, no. 10 (2022). https://doi.org/10.1093/ckj/sfac142.

MLA (9th ed.) Citation

Hammer, Fabian, et al. "Soluble Suppression of Tumorigenesis-2 Is a Strong Predictor of All-cause, Cardiovascular and Infection-related Mortality Risk in Haemodialysis Patients with Diabetes Mellitus." Clinical Kidney Journal, vol. 15, no. 10, 2022, https://doi.org/10.1093/ckj/sfac142.